Capital Management Associates (New York)’s Merck MRK Stock Holding History

Capital Management Associates (New York)’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-5,161	Closed	-$381K	–	74
2020 Q2	$381K	Sell	5,161 -3,275	-39%	-$247K	0.54%	61
2020 Q1	$619K	Buy	8,436 +2,934	+53%	+$231K	1.12%	37
2019 Q4	$477K	Sell	5,502 -419	-7%	-$34.4K	0.66%	57
2019 Q3	$476K	Buy	5,921 +1,048	+22%	+$84K	0.74%	51
2019 Q2	$390K	Hold	4,873	–	–	0.63%	72
2019 Q1	$387K	Hold	4,873	–	–	0.6%	71
2018 Q4	$355K	Hold	4,873	–	–	0.67%	66
2018 Q3	$330K	Hold	4,873	–	–	0.41%	113
2018 Q2	$282K	Buy	+4,873	New	+$275K	0.35%	121

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Management Associates (New York)'s MRK Position: Q3 2020 in Review

Capital Management Associates (New York) sold out of Merck (MRK) in Q3 2020, closing a stake of 5,161 shares — an estimated $381K sold.

Capital Management Associates (New York) first reported a position in MRK in Q2 2018 and held it in 9 quarters. The position peaked at $619K in Q1 2020. 2,559 funds tracked by Wall St. Rank hold MRK as of Q3 2020.

Capital Management Associates (New York) reported no remaining Merck position as of Q3 2020 after selling out during the quarter.
Capital Management Associates (New York) sold 5,161 Merck shares in Q3 2020, an estimated $381K.
Capital Management Associates (New York) first reported a position in Merck in Q2 2018 and held it in 9 quarters.
Capital Management Associates (New York)'s Merck position peaked at $619K in Q1 2020.
2,559 funds tracked by Wall St. Rank held Merck as of Q3 2020.

Based on Capital Management Associates (New York)'s 13F filing for Q3 2020, filed 10 Nov 2020.